[Idarucizumab and dabigatran. Data from the RE-VERSE AD study]
- PMID: 26640136
- DOI: 10.1016/j.semerg.2015.09.013
[Idarucizumab and dabigatran. Data from the RE-VERSE AD study]
Comment on
-
Idarucizumab for Dabigatran Reversal.N Engl J Med. 2015 Aug 6;373(6):511-20. doi: 10.1056/NEJMoa1502000. Epub 2015 Jun 22. N Engl J Med. 2015. PMID: 26095746 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical